Showing results (331-340 of 538) with videos related to

Sort By:
Pageof 54
Rheumatology (Oxford, England)|September 29, 2017
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATEJacques Morel, Arnaud Constantin, Gabriel Baron, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohortDewi Guellec, Guillermo Carvajal-Alegria, Claire Daïen, et al.
Joint Bone Spine|August 19, 2007
Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosisJérémie Sellam, Nathalie Costedoat-Chalumeau, Zahir Amoura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trialJérémie Sellam, Sandrine Marion-Thore, Florent Dumont, et al.
Epigenetics|October 4, 2021
CD4+ T-cell DNA methylation changes during pregnancy significantly correlate with disease-associated methylation changes in autoimmune diseasesTejaswi V Badam, Sandra Hellberg, Ratnesh B Mehta, et al.
Joint Bone Spine|July 18, 2006
TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for RheumatologyThao Pham, Francis Guillemin, Pascal Claudepierre, et al.
RMD Open|October 31, 2020
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programmeStanley B Cohen, Yoshiya Tanaka, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|February 2, 2017
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trialsStanley B Cohen, Yoshiya Tanaka, Xavier Mariette, et al.
Medicine|June 10, 2016
Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational StudyAnne Claire Desbois, Olga Addimanda, Anne Bertrand, et al.
The Lancet. Rheumatology|June 22, 2026
Aligning approaches to rheumatoid arthritis drug development: a comparison of FDA and EMA guidanceAntonio Ciancio, Andrea Amati, Saviana Gandolfo, et al.
Pageof 54